Milk Exosomes: Perspective Agents for Anticancer Drug Delivery
- PMID: 32932782
- PMCID: PMC7555228
- DOI: 10.3390/ijms21186646
Milk Exosomes: Perspective Agents for Anticancer Drug Delivery
Abstract
Exosomes are biological nanovesicles that participate in intercellular communication by transferring biologically active chemical compounds (proteins, microRNA, mRNA, DNA, and others). Due to their small size (diameter 40-100 nm) and high biological compatibility, exosomes are promising delivery tools in personalized therapy. Because artificial exosome synthesis methods are not developed yet, the urgent task is to develop an effective and safe way to obtain exosomes from natural sources. Milk is the only exosome-containing biological fluid that is commercially available. In this regard, milk exosomes are unique and promising candidates for new therapeutic approaches to treating various diseases, including cancer. The appearance of side effects during the use of cytotoxic and cytostatic agents is among the main problems in cancer chemotherapy. According to this, the targeted delivery of chemotherapeutic agents can be a potential solution to the toxic effect of chemotherapy. The ability of milk exosomes to carry out biologically active substances to the cell makes them promising tools for oral delivery of chemotherapeutic agents. This review is devoted to the methods of milk exosome isolation, their biological components, and prospects for their use in cancer treatment.
Keywords: cancer; drug delivery; exosomes; isolation; milk; milk exosomes; vesicles.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Milk Exosomes: Next-Generation Agents for Delivery of Anticancer Drugs and Therapeutic Nucleic Acids.Int J Mol Sci. 2023 Jun 15;24(12):10194. doi: 10.3390/ijms241210194. Int J Mol Sci. 2023. PMID: 37373342 Free PMC article. Review.
-
Exosome-like Nanovectors for Drug Delivery in Cancer.Curr Med Chem. 2019;26(33):6132-6148. doi: 10.2174/0929867325666180831150259. Curr Med Chem. 2019. PMID: 30182846 Free PMC article. Review.
-
Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.Int J Mol Sci. 2020 Dec 22;22(1):14. doi: 10.3390/ijms22010014. Int J Mol Sci. 2020. PMID: 33374978 Free PMC article. Review.
-
Exosomes as Targeted Delivery Drug System: Advances in Exosome Loading, Surface Functionalization and Potential for Clinical Application.Curr Drug Deliv. 2024;21(4):473-487. doi: 10.2174/1567201819666220613150814. Curr Drug Deliv. 2024. PMID: 35702803 Review.
-
Exosomes: Isolation, Analysis, and Applications in Cancer Detection and Therapy.Chembiochem. 2019 Feb 15;20(4):451-461. doi: 10.1002/cbic.201800470. Epub 2018 Dec 7. Chembiochem. 2019. PMID: 30371016 Review.
Cited by
-
Potential therapeutic effects of milk-derived exosomes on intestinal diseases.J Nanobiotechnology. 2023 Dec 20;21(1):496. doi: 10.1186/s12951-023-02176-8. J Nanobiotechnology. 2023. PMID: 38115131 Free PMC article. Review.
-
Milk Exosomes: Next-Generation Agents for Delivery of Anticancer Drugs and Therapeutic Nucleic Acids.Int J Mol Sci. 2023 Jun 15;24(12):10194. doi: 10.3390/ijms241210194. Int J Mol Sci. 2023. PMID: 37373342 Free PMC article. Review.
-
Comparison of proteomic landscape of extracellular vesicles in pleural effusions isolated by three strategies.Front Bioeng Biotechnol. 2023 Apr 12;11:1108952. doi: 10.3389/fbioe.2023.1108952. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37122867 Free PMC article.
-
Analysis of Proteins and Peptides of Highly Purified CD9+ and CD63+ Horse Milk Exosomes Isolated by Affinity Chromatography.Int J Mol Sci. 2022 Dec 17;23(24):16106. doi: 10.3390/ijms232416106. Int J Mol Sci. 2022. PMID: 36555744 Free PMC article.
-
Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection.Biol Direct. 2022 Nov 14;17(1):31. doi: 10.1186/s13062-022-00345-7. Biol Direct. 2022. PMID: 36376978 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
